Management of relapse in naltrexone maintenance for heroin dependence. - Test2 - elhamkhani - TriplyDB

Management of relapse in naltrexone maintenance for heroin dependence.

Management of relapse in naltrexone maintenance for heroin dependence.

http://www.wikidata.org/entity/Q34128519

about

Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.Opioid dependence treatment: options in pharmacotherapy.Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.Pharmacological enhancement of naltrexone treatment for opioid dependence: a review Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence Early outcomes following low dose naltrexone enhancement of opioid detoxification.Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain.Long-acting injectable naltrexone for the management of patients with opioid dependence.Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.Animal models for opioid addiction drug discovery.NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.Favorable mortality profile of naltrexone implants for opiate addiction.Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.Opioid antagonists with minimal sedation for opioid withdrawal

P2860

Q33704889-362C64EB-7F4A-4C06-9F17-4DD51097A433 Q33868638-A9C8C38B-FBD0-4B18-AA1A-D282EC965AA9 Q35023989-B48B2773-9CC9-455D-9CAF-0615D10806E2 Q35084340-64FE51E1-6985-45A0-8544-F01941893947 Q35090939-626BFE51-D770-40DF-B4B3-9947F93AD93F Q35118798-F0535295-E8F9-4E70-B7EB-64B50CF469AF Q35161399-49AEF08A-C400-4BDB-94D2-599ED6F21C1B Q35303819-36A40208-4740-4731-AFDA-5E14A0AD4222 Q35599780-3BE4B2C5-1FFF-4453-94C9-23D67AD8E835 Q35633106-43C63ACE-958A-44B5-9411-AD334013AFD8 Q35670689-796E8ED7-64AD-4023-BCA9-08A94B566E88 Q36110773-69B75A01-B6ED-409F-8E0C-DB5C7806EC6F Q36139018-609181AC-5E4C-4988-A307-54DCCE2B3CE6 Q36808909-DEF78ACC-301A-470F-B6F6-3CB1CD911626 Q37700707-AB29B986-BDCB-4988-8E79-2FC51BBAC303 Q37999447-23571937-05F5-4CDE-87E8-A110E8F4E31D Q38259272-A79D6983-C30B-4A06-8592-D90BD8E5B97E Q42289728-845CE40C-5797-46E4-9CF6-5B3A2C746D36 Q43100374-AC356FB1-70EA-4F9F-ADC7-4CF962253C8D Q44252264-AEA4742D-664C-40CB-8297-169C1C8443B9 Q47434083-F955D206-924F-4718-871D-37B5353A79A8 Q52311312-8B68AFA2-CFAE-4080-A4E8-8EE5D74B0A9D Q52317035-469003FD-531A-4FE3-A170-51A5FAC97BF2 Q56289303-C073B392-C7A5-4096-BBD1-A0F9AEF0AFAE

P2860

Management of relapse in naltrexone maintenance for heroin dependence.

http://www.wikidata.org/entity/Q34128519

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Management of relapse in naltrexone maintenance for heroin dependence.

@ast

Management of relapse in naltrexone maintenance for heroin dependence.

@en

Management of relapse in naltrexone maintenance for heroin dependence.

@nl

type

label

Management of relapse in naltrexone maintenance for heroin dependence.

@ast

Management of relapse in naltrexone maintenance for heroin dependence.

@en

Management of relapse in naltrexone maintenance for heroin dependence.

@nl

prefLabel

Management of relapse in naltrexone maintenance for heroin dependence.

@ast

Management of relapse in naltrexone maintenance for heroin dependence.

@en

Management of relapse in naltrexone maintenance for heroin dependence.

@nl

P1433

Q34128519-76B6B360-2B1C-478F-BBEE-F9AF1A01F486

P1476

Q34128519-1980E716-13A4-4146-8FDB-7B45F6D9CB95

P2093

Q34128519-20C15F87-622B-4F0D-9504-CAA415B3B055

Q34128519-2280C82B-89E7-44AF-A2CD-AD4E743BE0E8

Q34128519-2A3A5823-01C6-4987-91B4-1CBC57553EB9

Q34128519-2E7ACA64-3D4C-44E6-B4E2-8CD4AFCCEB9C

Q34128519-46226FA8-0A1B-4CBD-A937-832AD0D68049

Q34128519-624D61B4-297D-477D-BD68-85E8D265DD28

Q34128519-670F8F28-3F7C-4D31-A4C5-B772D46F2D65

Q34128519-7EC67148-DF6B-48AD-ABCF-BB7F52A0B4CB

Q34128519-80162643-5C31-44D3-AD73-49C1F19B7F28

Q34128519-889BE98A-7528-4E7E-9D8B-950584C611D2

P2860

Q34128519-18082FBC-2B33-4AF1-81FC-5A4ADF752296

Q34128519-1814B42A-C7FE-40A9-B908-CD6A468C256A

Q34128519-1DB7F5B7-0EA2-47BE-8B1A-28AF0F8A2E52

Q34128519-1EDD8146-0983-4650-831A-1B9C4DE1109E

Q34128519-237665FD-ABC5-4A32-B05B-FEAD275B138D

Q34128519-30EFF060-01CF-4E05-957B-A43F19119B97

Q34128519-3120E3F4-0081-4492-9823-2BB18CFE3226

Q34128519-31575090-8569-4DAE-913F-2E8C059A1E8A

Q34128519-37BBAE25-34A6-45FA-83FE-4D62AF0CEE90

Q34128519-3923704F-0440-430E-9C25-D387D41A523A

P304

Q34128519-F6213E3C-457C-4C88-9383-B5BA540E65FE

P31

Q34128519-5BE415A4-2A89-4777-9D5D-38939344A5F9

P356

Q34128519-043ABB43-9192-4C16-9CC6-B00363DE0A8E

P433

Q34128519-2E80C305-615F-43C8-9890-7FC5803D64A7

P478

Q34128519-3D47FF3C-FBE6-4D75-ABD9-767EB00E064D

P50

Q34128519-29D4E050-A3E1-4897-A72C-301273EDC77C

P577

Q34128519-ABCF1E89-EC1B-4DB2-91C3-C726ACF2258E

P698

Q34128519-3ED7BB08-A7EA-46C5-8B4E-2281851BE459

P921

Q34128519-BF3F6B2D-DC9C-43CA-92C1-15E5FFF8830C

P932

Q34128519-4AA3CAB0-A0A4-4259-8477-2463FD582E9A

P356

J.DRUGALCDEP.2007.06.013

P1433

Drug and Alcohol Dependence

P1476

Management of relapse in naltrexone maintenance for heroin dependence.

@en

P2093

Adam C Brooks

http://www.w3.org/2001/XMLSchema#string

Edward V Nunes

http://www.w3.org/2001/XMLSchema#string

Evaristo Akerele

http://www.w3.org/2001/XMLSchema#string

Fatima Garawi

http://www.w3.org/2001/XMLSchema#string

Huiping Jiang

http://www.w3.org/2001/XMLSchema#string

Kenneth Carpenter

http://www.w3.org/2001/XMLSchema#string

Maria A Sullivan

http://www.w3.org/2001/XMLSchema#string

Sandra D Comer

http://www.w3.org/2001/XMLSchema#string

Stephen J Anen

http://www.w3.org/2001/XMLSchema#string

Wilfrid N Raby

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of naltrexone on alcohol and cocaine use in dually addicted patients

Mechanisms of fatal opioid overdose.

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose.

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.

Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Naltrexone and relapse prevention treatment for cocaine-dependent patients.

Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts.

P304

289-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2007.06.013

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17681716

http://www.w3.org/2001/XMLSchema#string

P921

P932

4153601

http://www.w3.org/2001/XMLSchema#string